Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one dose. By combining two immune-boosting adjuvants alum and SMNP the vaccine lingers in lymph nodes for nearly a month, encouraging the body to produce a vast array of antibodies. This one-shot strategy could revolutionize how we fight not just HIV, but many infectious diseases. It mimics the natural infection process and opens the door to broadly neutralizing antibody responses, a holy grail in vaccine design. And best of all, it's built on components already known to medicine.
  • some_guy@lemmy.sdf.orgEnglish
    0·
    21 days ago

    And MAHA will continue Reagan’s proud tradition of not talking about the issue. Circle complete.

    Seriously, though. This is great news.

      • pyre@lemmy.world
        0·
        21 days ago

        MAHA is their HHS wing, led by the parasite that died in JFK’s head after eating his brain, so I assume it died from lack of nutrients.

        it’s short for make America healthy again. maybe they’re going for irony, idk, because horrendous times are a-coming for the states the more of his policies are enacted.

  • ryedaft@sh.itjust.worksEnglish
    0·
    21 days ago

    This doesn’t say anything about whether their new vaccine protects against HIV.

    But they took a classic adjuvant, alum, and combined it with a novel adjuvant (this new adjuvant actually two adjuvants combined to a nanoparticle). The antigens (what the immune system recognizes) stayed in the lymph nodes for 4 weeks and there were 3x more unique antibodies produced by the mice.